Corbus Pharmaceuticals Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   TEMPO-1 · CRB-701 Compared to Investigator's Choice Therapy in…TEMPO-1 · CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

   Recruitment opened

   Also in this update: Trial sites expanded: 29 → 111 locations; Start date changed from estimate of Sep 20, 2026 to Sep 29, 2026

   Corbus Pharmaceuticals Inc.·Phase 3· NCT07768189· Registry history of NCT07768189 on ClinicalTrials.gov (opens the registry)

   Updated Oct 8, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.